Extended antiretroviral prophylaxis to reduce breast-milk HIV-1 transmission.
about
Prevention of vertical transmission of HIV-1 in resource-limited settingsAntiretroviral interventions for preventing breast milk transmission of HIVInterventions for preventing late postnatal mother-to-child transmission of HIVTenascin-C is an innate broad-spectrum, HIV-1-neutralizing protein in breast milkThe development of antiretroviral therapy and its impact on the HIV-1/AIDS pandemicPreexposure prophylaxis for HIV prevention: where have we been and where are we going?Preventing HIV infection: pre-exposure and postexposure prophylaxisCurrent knowledge and future research on infant feeding in the context of HIV: basic, clinical, behavioral, and programmatic perspectivesAntiretroviral drug regimens to prevent mother-to-child transmission of HIV: a review of scientific, program, and policy advances for sub-Saharan AfricaA systematic review of interventions to improve postpartum retention of women in PMTCT and ART careAntiretroviral prophylaxis for HIV prevention in heterosexual men and womenHIV-1 drug resistance emergence among breastfeeding infants born to HIV-infected mothers during a single-arm trial of triple-antiretroviral prophylaxis for prevention of mother-to-child transmission: a secondary analysisWhat will it take to eliminate pediatric HIV? Reaching WHO target rates of mother-to-child HIV transmission in Zimbabwe: a model-based analysisExclusive breastfeeding, diarrhoeal morbidity and all-cause mortality in infants of HIV-infected and HIV uninfected mothers: an intervention cohort study in KwaZulu Natal, South AfricaWomen's preferences regarding infant or maternal antiretroviral prophylaxis for prevention of mother-to-child transmission of HIV during breastfeeding and their views on Option B+ in Dar es Salaam, TanzaniaPre-exposure prophylaxis for the prevention of HIV infection in high risk populations: a meta-analysis of randomized controlled trialsFactors associated with HIV infection among children born to mothers on the prevention of mother to child transmission programme at Chitungwiza Hospital, Zimbabwe, 2008.The rhesus macaque pediatric SIV infection model - a valuable tool in understanding infant HIV-1 pathogenesis and for designing pediatric HIV-1 prevention strategiesSetting the stage: current state of affairs and major challenges.Analysis of HIV early infant diagnosis data to estimate rates of perinatal HIV transmission in ZambiaPooled individual data analysis of 5 randomized trials of infant nevirapine prophylaxis to prevent breast-milk HIV-1 transmission.Survival of infants born to HIV-positive mothers, by feeding modality, in Rakai, Uganda.Nevirapine resistance and breast-milk HIV transmission: effects of single and extended-dose nevirapine prophylaxis in subtype C HIV-infected infantsDifferential effects of early weaning for HIV-free survival of children born to HIV-infected mothers by severity of maternal diseaseDuration, pattern of breastfeeding and postnatal transmission of HIV: pooled analysis of individual data from West and South African cohortsTask shifting routine inpatient pediatric HIV testing improves program outcomes in urban Malawi: a retrospective observational studyHIV prevention is not enough: child survival in the context of prevention of mother to child HIV transmissionAntiretroviral treatment in HIV-infected infants and young children: novel issues raised by the Mississippi babyElevations in mortality associated with weaning persist into the second year of life among uninfected children born to HIV-infected mothers.Sociocultural and epidemiological aspects of HIV/AIDS in Mozambique.Infant feeding counselling in Uganda in a changing environment with focus on the general population and HIV-positive mothers - a mixed method approach.Milk mysteries: Why are women who exclusively breast-feed less likely to transmit HIV during breast-feeding?Timing and determinants of mother-to-child transmission of HIV in Nigeria.Oral pre-exposure prophylaxis by anti-retrovirals raltegravir and maraviroc protects against HIV-1 vaginal transmission in a humanized mouse model.Beyond prevention of mother-to-child transmission: keeping HIV-exposed and HIV-positive children healthy and aliveHIV: prevention of mother-to-child transmission.Antiretroviral drugs for preventing mother-to-child transmission of HIV in sub-Saharan Africa: balancing efficacy and infant toxicity.Interactive weekly mobile phone text messaging plus motivational interviewing in promotion of breastfeeding among women living with HIV in South Africa: study protocol for a randomized controlled trialEarly weaning of HIV-exposed uninfected infants and risk of serious gastroenteritis: Findings from two perinatal HIV prevention trials in Kampala, Uganda.Use of antiretrovirals during pregnancy and breastfeeding in low-income and middle-income countries.
P2860
Q22241479-931058AF-67A9-4EA8-A850-083B53E03D9BQ22252958-6E2282F2-DEB1-4516-8D2D-3EC64B076F65Q24241793-E2EA0DF3-1F91-49A9-B2EC-160DA89B3D17Q24598653-5353AF9C-3BE2-4842-9854-8AF0CB8BDA51Q24655011-0989F267-DEEE-42F2-9EC1-02697E75529DQ26825042-03838FE4-C3CF-46D8-8E6E-83A5B3DCBAF1Q26828445-D24F2DAB-5EBA-4CAF-A4CE-C96533DA2406Q27000260-04D59C28-5809-4E98-BEF7-46A49B99F483Q27014960-8E68ABE7-50D0-498D-93A6-A9D3E07809B5Q28069308-1AD91785-0FE5-4DA1-9DC2-D4A8D231EDBCQ28270788-C01F8FE9-14EE-4F47-9559-BA1120067B45Q28477542-8148D6EB-0A40-4CC3-89CC-B008D5B8875AQ28478769-20E93DE2-1241-4562-9854-0A2CB9B6B04CQ28535608-9FF4F6F3-7962-4085-ABC2-4415A554BBBBQ28538970-CC3B045E-A379-4BF1-9AC5-67CEEBFB1B9EQ28539443-EEDA2DF5-B164-4540-A04C-42B494E18484Q30356701-2BE2B922-C330-4270-8901-81E5F5FB30F0Q30374404-B0660717-E85F-4B53-AAC4-EB2C50CA432AQ30388160-76BE7CF1-86E8-480A-B851-3C9923276B0FQ30558708-8109D46E-9984-4D97-B079-4913327F866EQ30569674-44132D43-FAF0-40E2-BAB2-3C48ECD97FB4Q33391079-BAD21059-1EC7-4ADE-8A72-B646B9A0C053Q33396950-E459AE79-5F4E-4567-820F-32C8B158B840Q33474822-1743C00D-E92D-4F7F-A928-90D4804974FFQ33510928-CF6FF171-F3D9-47E0-BB32-645942F0F24AQ33540181-7EA8BC07-3AC2-4434-BBC9-02668833781AQ33552646-6940FE5E-B418-41E1-900B-9DE4FFB44092Q33557037-E9C12471-317E-4F73-8569-D7999A014EA3Q33587760-4595AA56-675E-40B3-A468-9E56A5ABF851Q33597085-43F03778-944E-46F1-9887-87DAFC682D7EQ33684064-8F766C39-3D86-45DC-AA07-25CEB0E9AA62Q33744125-B33930B7-6957-4A54-8129-34156AE07B67Q33769871-8A3BB1B6-DA3C-4EF4-B624-E27E95F882C4Q33784852-F403E565-66D9-405E-B386-71A73BC3B785Q33865236-C51EA5FA-A09D-4D3E-81F4-EDCB170CE25BQ33866493-7BD69BFB-932E-4F11-B5E3-567BD4C2D72CQ33897042-67251DF9-5F84-4BC4-903C-0E053F0EC83AQ33910751-8EBEFA50-DF15-4250-AB46-D300DE9074BAQ33926411-1551259D-D443-46F6-90B6-FCF15E269A62Q34081586-5185D407-0EEF-480A-9B92-86A0F7C6E992
P2860
Extended antiretroviral prophylaxis to reduce breast-milk HIV-1 transmission.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Extended antiretroviral prophylaxis to reduce breast-milk HIV-1 transmission.
@en
Extended antiretroviral prophylaxis to reduce breast-milk HIV-1 transmission.
@nl
type
label
Extended antiretroviral prophylaxis to reduce breast-milk HIV-1 transmission.
@en
Extended antiretroviral prophylaxis to reduce breast-milk HIV-1 transmission.
@nl
prefLabel
Extended antiretroviral prophylaxis to reduce breast-milk HIV-1 transmission.
@en
Extended antiretroviral prophylaxis to reduce breast-milk HIV-1 transmission.
@nl
P2093
P50
P356
P1476
Extended antiretroviral prophylaxis to reduce breast-milk HIV-1 transmission.
@en
P2093
Donald R Hoover
George Kafulafula
Kondwani Nkanaunena
Linda Mipando
Mary Glenn Fowler
Michael C Thigpen
Tsedal Mebrahtu
P304
P356
10.1056/NEJMOA0801941
P407
P577
2008-06-04T00:00:00Z